DCF — BAYONNE MEDICAL CENTER
Enterprise Value: $-125.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-125.0M
Enterprise Value
$-41.8M
PV of Cash Flows
$-83.2M
PV of Terminal Value
$-134.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $145.6M | $-6.6M | -4.0% | $-12.7M | $-11.6M |
| Year 2 | $150.0M | $-5.2M | -3.0% | $-11.6M | $-9.6M |
| Year 3 | $154.5M | $-3.9M | -2.0% | $-10.4M | $-7.8M |
| Year 4 | $159.1M | $-3.2M | -2.0% | $-9.9M | $-6.8M |
| Year 5 | $163.9M | $-2.9M | -2.0% | $-9.8M | $-6.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-125.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$141.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999681711501
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5